{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:57:03Z","timestamp":1773194223645,"version":"3.50.1"},"reference-count":106,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>This manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to provide recommendations for some important aspects management of patients with colorectal peritoneal metastases (CPM) and address some issues unique to India.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>The modified Delphi technique was used with two rounds of voting. There were 29 questions on nine main topics\u2014the role of cytoreductive surgery (CRS), patient selection for CRS, preoperative workup, role of systemic chemotherapy (SC), CPM with other visceral metastases, molecular profile, hyperthermic intraperitoneal chemotherapy (HIPEC) and other modalities of intraperitoneal chemotherapy (IPC), prophylactic\/preventive strategies, and surveillances after CRS. A consensus was achieved if anyone option received &gt;70 votes (strong consensus &gt;90%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              Forty-eight surgical (n = 41) and gastrointestinal (n = 7) oncologists were invited; 44 agreed to participate. The response rate was 95.4% (42\/44) in round 1 and 93.1% (41\/44) in round 2. Overall, a consensus was achieved on 23\/29 (79.3%) questions (strong consensus on 6\/29 [20.6%]). The panel strongly recommended considering surgery for limited CPM with limited liver metastases (92.5%), not altering the surgical approach in patients with\n              <jats:italic>KRAS<\/jats:italic>\n              mutations (91.67%), and limiting the use of IPC for unresectable CPM outside clinical trials (95%). Adjuvant SC was recommended for all patients undergoing CRS (89.47%). CRS is a therapeutic option for selected patients with CPM including those with metachronous CPM (79.49) and signet ring cell cancers (76.92%). HIPEC was recommended outside clinical trials only for patients with peritoneal cancer index 11-15(80%).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The panel recommended CRS for most indications but was very selective in recommending HIPEC and IPC outside clinical trials. These recommendations should be a useful resource in clinical decision making for clinicians treating CPM in India and regions with a similar sociodemographic background.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00306","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:59:29Z","timestamp":1733432369000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":4,"title":["INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-3271","authenticated-orcid":true,"given":"Swapnil","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Upkar Hospital and Cancer Institute, Varanasi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-0237","authenticated-orcid":true,"given":"Ramakrishnan Ayloor","family":"Sheshadri","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Cancer Institute WIA, Adyar, Chennai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-7612","authenticated-orcid":true,"given":"Avanish","family":"Saklani","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery and GI Surgery, Tata Memorial Hospital, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-1625","authenticated-orcid":true,"given":"Somashekhar","family":"SP","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Aster International Institute of Oncology, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-3643","authenticated-orcid":true,"given":"Rohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Aster International Institute of Oncology, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-9545","authenticated-orcid":true,"given":"Shivendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of GI and HPB Surgery, Rajiv Gandhi Cancer Institute, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-6770","authenticated-orcid":true,"given":"Vivek","family":"Sukumar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Specialty Surgical Oncology, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6898","authenticated-orcid":true,"given":"Aditi","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00675-5"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.187"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9966-2"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4238"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30599-4"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30500-9"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003"},{"key":"e_1_3_5_9_2","unstructured":"NCCN guidelines for colon cancer. https:\/\/www.nccn.org"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.05.023"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-023-01727-7"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/ijmpo.ijmpo_187_16","article-title":"Is colorectal cancer in young (<40 years) different from those in the elderly (>40 years): Experience from a regional care centre","volume":"38","author":"Haleshappa RA","year":"2017","unstructured":"Haleshappa RA, Rao SA, Garg S, et al: Is colorectal cancer in young (<40 years) different from those in the elderly (>40 years): Experience from a regional care centre. Indian J Med Paediatr Oncol 38:466-470, 2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/sjmms.sjmms_260_23","article-title":"Spatial epidemiology of signet-ring cell colorectal cancer in India","volume":"12","author":"Kazi M","year":"2024","unstructured":"Kazi M, Patel H, Choudhary N, et al: Spatial epidemiology of signet-ring cell colorectal cancer in India. Saudi J Med Med Sci 12:71-75, 2024","journal-title":"Saudi J Med Med Sci"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.09.017"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9285"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-019-00879-9"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002899"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13150-x"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"106571","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Goere D","year":"2013","unstructured":"Goere D, Malka D, Tzanis D, et al: Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257:106571, 2013","journal-title":"Ann Surg"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7800-2-3"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Portilla AG","year":"2008","unstructured":"Portilla AG, Shigeki K, Dario B, et al: The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 98:228-231, 2008","journal-title":"J Surg Oncol"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9185-7"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/978394","article-title":"Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy","volume":"2013","author":"Yonemura Y","year":"2013","unstructured":"Yonemura Y, Canbay E, Ishibashi H: Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. ScientificWorldJournal 2013:1-7, 2013","journal-title":"ScientificWorldJournal"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.08.023"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164922"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4627-8"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4387-5"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3145-9"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2019.06.002"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.3747\/co.27.6919","article-title":"Canadian guidelines on the management of colorectal peritoneal metastases","volume":"27","author":"Brind'Amour A","year":"2020","unstructured":"Brind'Amour A, Dub\u00e9 P, Tremblay JF, et al: Canadian guidelines on the management of colorectal peritoneal metastases. Curr Oncol 27:e621-e631, 2020","journal-title":"Curr Oncol"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000513353","article-title":"The accuracy of the surgical peritoneal cancer index in patients with peritoneal metastases of colorectal cancer","volume":"38","author":"de Boer NL","year":"2021","unstructured":"de Boer NL, Brandt-Kerkhof ARM, Madsen EVE, et al: The accuracy of the surgical peritoneal cancer index in patients with peritoneal metastases of colorectal cancer. Dig Surg 38:205-211, 2021","journal-title":"Dig Surg"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1245\/s10434-020-08234-x","article-title":"The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors","volume":"27","author":"Bhatt A","year":"2020","unstructured":"Bhatt A, Yonemura Y, Mehta S, et al: The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors. Ann Surg Oncol 27:2985-2996, 2020","journal-title":"Ann Surg Oncol"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.07.039"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2015.05.011"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25379"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.03.008"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092536"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23784"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.03.014"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07294-y"},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1245\/s10434-021-10190-z","article-title":"Treatment strategies and prognosis of patients with synchronous or metachronous colorectal peritoneal metastases: A population-based study","volume":"28","author":"Bakkers C","year":"2021","unstructured":"Bakkers C, Lurvink RJ, Rijken A, et al: Treatment strategies and prognosis of patients with synchronous or metachronous colorectal peritoneal metastases: A population-based study. Ann Surg Oncol 28:9073-9083, 2021","journal-title":"Ann Surg Oncol"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.21037\/ales.2019.07.10","article-title":"Right sided colon cancer and peritoneal carcinomatosis","volume":"4","author":"Dong XD","year":"2019","unstructured":"Dong XD: Right sided colon cancer and peritoneal carcinomatosis. Ann Laparosc Endosc Surg 4:72, 2019","journal-title":"Ann Laparosc Endosc Surg"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.4227"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.07.027"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001593"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5211-6"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318254f281"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21169"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4516"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.10.007"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1351627"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1102\/1470-7330.2011.0016","article-title":"CT, MRI and PET imaging in peritoneal malignancy","volume":"11","author":"Patel CM","year":"2011","unstructured":"Patel CM, Sahdev A, Reznek RH: CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging 11:123-139, 2011","journal-title":"Cancer Imaging"},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jso.21069","article-title":"Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement","volume":"98","author":"Yan TD","year":"2008","unstructured":"Yan TD, Morris DL, Shigeki K, et al: Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 98:224-227, 2008","journal-title":"J Surg Oncol"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejso.2019.02.030","article-title":"Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation","volume":"47","author":"Low RN","year":"2021","unstructured":"Low RN, Barone RM, Rousset P: Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation. Eur J Surg Oncol 47:65-74, 2021","journal-title":"Eur J Surg Oncol"},{"key":"e_1_3_5_56_2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan A","year":"2017","unstructured":"Dohan A, Hoeffel C, Soyer P, et al: Evaluation of the peritoneal carcinomatosis index with CT and MRI. Br J Surg 104:1244-1249, 2017","journal-title":"Br J Surg"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02268-w"},{"key":"e_1_3_5_58_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/RLU.0000000000003611","article-title":"Use of 68Ga-FAPI PET\/CT for evaluation of peritoneal carcinomatosis before and after cytoreductive surgery","volume":"46","author":"Zhao L","year":"2021","unstructured":"Zhao L, Pang Y, Wei J, et al: Use of 68Ga-FAPI PET\/CT for evaluation of peritoneal carcinomatosis before and after cytoreductive surgery. Clin Nucl Med 46:491-493, 2021","journal-title":"Clin Nucl Med"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-015-0486-9"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijso.2020.12.011"},{"key":"e_1_3_5_61_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12885-021-08168-x","article-title":"Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial","volume":"21","author":"Engbersen MP","year":"2021","unstructured":"Engbersen MP, Rijsemus CJV, Nederend J, et al: Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial. BMC Cancer 21:464, 2021","journal-title":"BMC Cancer"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.03.028"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2701"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101746"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5712-3"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2018.07.011"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.1642"},{"key":"e_1_3_5_68_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jamasurg.2021.5024","article-title":"New insights on the treatment of colorectal peritoneal metastases from the CAIRO6 trial","volume":"157","author":"Bhatt A","year":"2022","unstructured":"Bhatt A, Passot G, Glehen O: New insights on the treatment of colorectal peritoneal metastases from the CAIRO6 trial. JAMA Surg 157:171, 2022","journal-title":"JAMA Surg"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs5.50179"},{"key":"e_1_3_5_70_2","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1245\/s10434-021-10925-y","article-title":"Outcomes of combined peritoneal and local treatment for patients with peritoneal and limited liver metastases of colorectal origin: A systematic review and meta-analysis","volume":"29","author":"Polderdijk MCE","year":"2022","unstructured":"Polderdijk MCE, Brouwer M, Haverkamp L, et al: Outcomes of combined peritoneal and local treatment for patients with peritoneal and limited liver metastases of colorectal origin: A systematic review and meta-analysis. Ann Surg Oncol 29:1952-1962, 2022","journal-title":"Ann Surg Oncol"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.07.038"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-017-0667-9"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/codi.14057"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9098(200011)75:3<186::AID-JSO6>3.0.CO;2-S"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.06.014"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07452-2"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01620-6"},{"key":"e_1_3_5_78_2","first-page":"735","article-title":"Microsatellite instability in colorectal cancer: Overview of its clinical significance and novel perspectives","volume":"16","author":"Battaglin F","year":"2018","unstructured":"Battaglin F, Naseem M, Lenz HJ, et al: Microsatellite instability in colorectal cancer: Overview of its clinical significance and novel perspectives. Clin Adv Hematol Oncol 16:735-745, 2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0805-8"},{"key":"e_1_3_5_81_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12876-021-02084-x","article-title":"Complete pathological response of colorectal peritoneal metastases in lynch syndrome after immunotherapy case report: Is a paradigm shift in cytoreductive surgery needed?","volume":"22","author":"Tonello M","year":"2022","unstructured":"Tonello M, Nappo F, Vassallo L, et al: Complete pathological response of colorectal peritoneal metastases in lynch syndrome after immunotherapy case report: Is a paradigm shift in cytoreductive surgery needed? BMC Gastroenterol 22:17, 2022","journal-title":"BMC Gastroenterol"},{"key":"e_1_3_5_82_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41571-022-00691-5","article-title":"From ESMO 2022","volume":"19","author":"Romero D","year":"2022","unstructured":"Romero D: From ESMO 2022. Nat Rev Clin Oncol 19:675, 2022","journal-title":"Nat Rev Clin Oncol"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182197102"},{"key":"e_1_3_5_84_2","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1245\/s10434-021-10205-9","article-title":"ASO author reflections: Standardizing HIPEC methodology and regimens: A prelude to the PSOGI expert consensus","volume":"28","author":"Bhatt A","year":"2021","unstructured":"Bhatt A, Van Der Speeten K, Hubner M, et al: ASO author reflections: Standardizing HIPEC methodology and regimens: A prelude to the PSOGI expert consensus. Ann Surg Oncol 28:9114-9115, 2021","journal-title":"Ann Surg Oncol"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.012"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2015.1135485"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2016-0018"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2152"},{"key":"e_1_3_5_89_2","doi-asserted-by":"crossref","first-page":"20200109","DOI":"10.1515\/pp-2020-0109","article-title":"Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients","volume":"5","author":"Elleb\u00e6k SB","year":"2020","unstructured":"Elleb\u00e6k SB, Graversen M, Detlefsen S, et al: Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum 5:20200109, 2020","journal-title":"Pleura Peritoneum"},{"key":"e_1_3_5_90_2","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: A multicenter, single-arm, phase II trial (CRC-PIPAC)","volume":"28","author":"Rovers KP","year":"2021","unstructured":"Rovers KP, Wassenaar ECE, Lurvink RJ, et al: Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: A multicenter, single-arm, phase II trial (CRC-PIPAC). Ann Surg Oncol 28:5311-5326, 2021","journal-title":"Ann Surg Oncol"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3714-5"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30239-0"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30322-3"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4096-0"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07526-1"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.07.019"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14368-5"},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.09.035"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174275"},{"key":"e_1_3_5_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32874"},{"key":"e_1_3_5_101_2","volume-title":"Pathology of Peritoneal Metastases","author":"Bhatt A","year":"2020","unstructured":"Bhatt A, Glehen O: Colorectal peritoneal metastases: Correlating histopathological findings and disease biology, in Glehen O, Bhatt A (eds): Pathology of Peritoneal Metastases. Singapore, Springer, 2020"},{"key":"e_1_3_5_102_2","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1245\/s10434-021-10289-3","article-title":"Definition and prediction of early recurrence and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Towards predicting oncologic futility preoperatively","volume":"28","author":"Rieser CJ","year":"2021","unstructured":"Rieser CJ, Jones H, Hall LB, et al: Definition and prediction of early recurrence and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Towards predicting oncologic futility preoperatively. Ann Surg Oncol 28:9116-9125, 2021","journal-title":"Ann Surg Oncol"},{"key":"e_1_3_5_103_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12957-024-03386-6","article-title":"Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: A systematic review","volume":"22","author":"Sarofim M","year":"2024","unstructured":"Sarofim M, Wijayawardana R, Ahmadi N, et al: Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: A systematic review. World J Surg Oncol 22:99, 2024","journal-title":"World J Surg Oncol"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-023-00959-8"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082383"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308795"},{"key":"e_1_3_5_107_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3798-z"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:59:56Z","timestamp":1733432396000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1200\/GO-24-00306"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00306","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400306"}}